<SEC-DOCUMENT>0001140361-23-006545.txt : 20230214
<SEC-HEADER>0001140361-23-006545.hdr.sgml : 20230214
<ACCEPTANCE-DATETIME>20230214080051
ACCESSION NUMBER:		0001140361-23-006545
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230214
DATE AS OF CHANGE:		20230214

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARIN CORP PLC\UK
		CENTRAL INDEX KEY:			0000897448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-52399
		FILM NUMBER:		23622619

	BUSINESS ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60
		BUSINESS PHONE:		353 1 6699 020

	MAIL ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMARIN PHARMACEUTICALS PLC
		DATE OF NAME CHANGE:	20000201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETHICAL HOLDINGS PLC
		DATE OF NAME CHANGE:	19930322

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sarissa Capital Management LP
		CENTRAL INDEX KEY:			0001577524
		IRS NUMBER:				900924432
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		660 STEAMBOAT ROAD
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
		BUSINESS PHONE:		203-302-2330

	MAIL ADDRESS:	
		STREET 1:		660 STEAMBOAT ROAD
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>ny20006859x19_sc13da.htm
<DESCRIPTION>SC 13D/A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.1.2.5118
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: center;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" align="center"><font style="font-weight: bold; font-size: 14pt;">UNITED




        STATES</font><br>
      <font style="font-size: 14pt;"> <font style="font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</font></font><br>
      <font style="font-size: 12pt;"> Washington, D.C. 20549</font></div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold; font-size: 18pt;">SCHEDULE 13D</div>
    <div><br>
    </div>
    <div style="text-align: center;">Under the Securities Exchange Act of 1934</div>
    <div style="text-align: center;">(Amendment No. 8)*<br>
      <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z742e3dc5131b442a8db0a31f3987960e" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 100%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">Amarin Corporation plc</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">(Name of Issuer)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">Ordinary Shares, par value 50 pence per share</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">(Title of Class of Securities)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">023111206</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">(CUSIP Number)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">Mark DiPaolo</div>
            <div style="text-align: center;">Senior Partner, General Counsel</div>
            <div style="text-align: center;">Sarissa Capital Management LP</div>
            <div style="text-align: center;">660 Steamboat Road</div>
            <div style="text-align: center;">Greenwich, CT 06830</div>
            <div style="text-align: center;">203-302-2330</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">(Name, Address and Telephone Number of Person<br>
              Authorized to Receive Notices and Communications)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">February 13, 2023</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top; border-top: #000000 2px solid;">
            <div style="text-align: center;">(Date of Event which Requires Filing of this Statement)</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g),
      check the following box. </div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Note:</font>&#160; Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies
      are to be sent.</div>
    <div>&#160;</div>
    <div>*The remainder of this cover page shall be filled out for a reporting person&#8217;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures
      provided in a prior cover page.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">The information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that
      section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).</div>
    <div><br>
    </div>
    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify;">
      <table id="zc678a84fa56a4e808ef039948ea557e3" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 33.33%;">
              <div style="text-align: left;">CUSIP No. 023111206</div>
            </td>
            <td style="width: 33.33%;">
              <div>&#160;</div>
            </td>
            <td style="width: 33.33%;">
              <div style="text-align: right; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt;">Page 2 of 4 Pages</font></div>
            </td>
          </tr>
          <tr>
            <td style="width: 33.33%;">
              <div>&#160;</div>
            </td>
            <td style="width: 33.33%;">
              <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">SCHEDULE 13D</div>
            </td>
            <td style="width: 33.33%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify;"> <br>
    </div>
    <div style="text-align: justify;">This Amendment No. 8 to Schedule 13D (&#8220;Amendment No. 8&#8221;) relates to American Depositary Shares (&#8220;ADS(s)&#8221;), each ADS representing one ordinary share, par value 50 pence per share (the &#8220;Ordinary Shares&#8221;), issued by
      Amarin Corporation plc, a company incorporated under the laws of England and Wales (the &#8220;Issuer&#8221;), and amends the initial statement on Schedule 13D filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on January 24, 2022 (the &#8220;Initial
      Schedule 13D&#8221;), as amended by Amendment No. 1 to Schedule 13D filed on June 3, 2022, Amendment No. 2 to Schedule 13D filed on June 16, 2022, Amendment No. 3 to Schedule 13D filed on October 11, 2022, Amendment No. 4 to Schedule 13D filed on January
      11, 2023, Amendment No. 5 to Schedule 13D filed on January 19, 2023, Amendment No. 6 to Schedule 13D filed on February 8, 2023, and Amendment No. 7 to Schedule 13D filed on February 10, 2023 (the Initial Schedule 13D as so amended, the &#8220;Schedule
      13D&#8221;). All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">This Amendment No. 8 is being filed to amend Item 4 and Item 7 as follows:</div>
    <div>&#160;</div>
    <div><font style="font-weight: bold;">Item 4.&#160; Purpose of Transaction. </font>Item 4 of the Schedule 13D is hereby amended to include the following:</div>
    <div>&#160;</div>
    <div style="text-align: justify;">On February 13, 2023, Sarissa Capital issued the press release attached as Exhibit 11 hereto.</div>
    <div>&#160;</div>
    <div style="text-align: justify;"><font style="font-weight: bold;">Item 7.&#160; Material to Be Filed as Exhibits. </font>Item 7 of the Schedule 13D is hereby amended to include the following:</div>
    <div>&#160;</div>
    <div>Exhibit 11 &#8211; Press Release, February 13, 2023</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <table id="f763b5fd9de64776b52f8f5d38374ec3" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 33.33%;">
            <div style="text-align: left;">CUSIP No. 023111206</div>
          </td>
          <td style="width: 33.33%;">&#160;</td>
          <td style="width: 33.33%;">
            <div style="text-align: right; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt;">Page 3 of 4 Pages</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%;">&#160;</td>
          <td style="width: 33.33%;">
            <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">SCHEDULE 13D</div>
          </td>
          <td style="width: 33.33%;">&#160;</td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">SIGNATURE</div>
    <div>&#160;</div>
    <div style="text-align: justify; text-indent: 36pt;">After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.</div>
    <div><br>
    </div>
    <div>Dated: February 13, 2023</div>
    <div><br>
    </div>
    <div>
      <table id="zcc37d38e32474bb0ae1340895c04e687" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td colspan="2" rowspan="1">SARISSA CAPITAL MANAGEMENT LP</td>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%;">
              <div>&#160;</div>
            </td>
            <td style="width: 45%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; padding-bottom: 2px;">By:</td>
            <td style="width: 45%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Mark DiPaolo</td>
            <td style="width: 50%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 5%;">&#160;</td>
            <td rowspan="1" style="width: 45%;">Name: Mark DiPaolo</td>
            <td rowspan="1" style="width: 50%;">&#160;</td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 5%;">&#160;</td>
            <td rowspan="1" style="width: 45%;">Title: Senior Partner, General Counsel</td>
            <td rowspan="1" style="width: 50%;">&#160;</td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <table id="z23f01c419616401b8009cca36e2d8c21" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Alexander J. Denner<br>
            </td>
            <td style="width: 50%; padding-bottom: 2px;">
              <div>&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50.00%;">Alexander J. Denner</td>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <table id="e4576d3803824bfcb157f2c01b430c3d" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 50%; border-bottom: 2px solid rgb(0, 0, 0);">/s/ Louis Sterling III</td>
          <td style="width: 50%; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50.00%;">Louis Sterling III</td>
          <td style="width: 50.00%;">&#160;</td>
        </tr>

    </table>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <table id="acc3ca7155804fcebb8138489867f76c" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 33.33%;">
            <div style="text-align: left;">CUSIP No. 023111206</div>
          </td>
          <td style="width: 33.33%;">&#160;</td>
          <td style="width: 33.33%;">
            <div style="text-align: right; font-family: 'Times New Roman',Times,serif; font-size: 12pt;"><font style="font-size: 10pt;">Page 4 of 4 Pages</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%;">&#160;</td>
          <td style="width: 33.33%;">
            <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">SCHEDULE 13D</div>
          </td>
          <td style="width: 33.33%;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">INDEX TO EXHIBITS</div>
    &#160;
    <div><a href="ny20006859x19_ex11.htm">Exhibit 11</a> &#8211; Press Release, February 13, 2023</div>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-11
<SEQUENCE>2
<FILENAME>ny20006859x19_ex11.htm
<DESCRIPTION>EXHIBIT 11
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.1.2.5118
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;"><font style="font-size: 10pt;"> </font>
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"><font style="font-size: 10pt;">Exhibit 11<br>
      </font>
      <div style="font-size: 10pt;"><br>
      </div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">SARISSA CAPITAL WARNS OF AMARIN&#8217;S EXPENSIVE ATTEMPTS TO SWITCH VOTES BY INUNDATING SHAREHOLDERS WITH WHITE PROXY CARDS</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">If You Already Voted a Proxy Card &#8220;FOR&#8221; the Sarissa Nominees and &#8220;FOR&#8221; the Removal of Chairman Per Wold-Olsen, There is NOTHING Else for You to Do</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">If You Have Any Questions or Have Not Yet Received a <font style="color: rgb(0, 32, 96);">BLUE </font>Proxy Card, Please Contact Sarissa&#8217;s Proxy
      Solicitor, D.F. King, by Calling (800) 331-7024</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">or Emailing <u>AMRN@dfking.com</u></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman',Times,serif;">Greenwich, CT, February 13, 2023 &#8211; Sarissa Capital Management LP (&#8220;Sarissa&#8221;) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):</div>
    <div>&#160;</div>
    <div style="font-family: 'Times New Roman',Times,serif;">Amarin continues to waste precious shareholder capital in its self-serving attempts to keep shareholders out of the board room. Amarin has indicated that it will spend in excess of $7 MILLION to
      prevent Sarissa Capital, its largest shareholder, from obtaining representation on the board. This amount is a whopping ~6X more than what Sarissa intends to spend in this proxy contest. The most recent waste of money comes in the form of several
      expensive and duplicative mailings of white proxy cards to shareholders in an attempt to sway votes away from Sarissa.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Although Sarissa is outraged by the Amarin board squandering shareholder capital for its own entrenchment, we are not surprised as there has been a history of reckless spending and self-serving,
      unjust enrichment at Amarin. Notably, compensation has been insensitive to shareholder returns. In 2021, when the stock declined &gt;31% and shareholders lost &gt;$560 million in value,* the board gave CEO Karim Mikhail over $5.8 million in total
      compensation. Similarly, we doubt CEO Karim Mikhail&#8217;s 2022 compensation will fully reflect the poor performance under his watch last year. In late 2022, the year in which the stock declined &gt;64% and shareholders lost over $840 million in value,<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#8224;</sup> new directors were gifted $540,000 in stock and option grants on joining. Chairman Per Wold-Olsen alone was granted approximately $1 million of stock, options and cash in
      2022.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#8225;</sup></div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Do not be misled by Amarin&#8217;s tactics to switch votes and do not be confused by the multiple mailings.&#160; If you already voted a proxy card &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the Sarissa
      Nominees and &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the Removal of Chairman Per Wold-Olsen, there is NOTHING else for you to do.&#160; <u>But any subsequent vote you make will revoke your prior vote.&#160; Only the last vote you submit will count.</u></div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">We urge all shareholders to vote the <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font><font style="color: rgb(0, 32, 96);">&#160;</font>proxy card &#8220;<font style="font-weight: bold;">FOR</font>&#8221;
      the Sarissa Nominees and &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the removal of Chairman Per Wold-Olsen.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">If you have not received a <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font><font style="color: rgb(0, 32, 96);">&#160;</font>proxy card, you can vote the white proxy card but you
      must vote &#8220;<font style="font-weight: bold;">FOR</font>&#8221; all proposals on the white proxy card to have the same effect as a vote &#8220;<font style="font-weight: bold;">FOR</font>&#8221; all proposals on the <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font> proxy card.&#160; Voting <font style="font-weight: bold;">&#8220;FOR&#8221;</font> on the white proxy card has the same effect as voting &#8220;<font style="font-weight: bold;">FOR</font>&#8221; on the <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font>
      proxy card.&#160; But if holders want to fully support Sarissa, they must make sure that all &#8220;<font style="font-weight: bold;">FOR</font>&#8221; boxes are marked on your proxy card before you submit it.&#160; <font style="font-weight: bold;">If you have any
        questions on how to vote, we recommend that you contact Sarissa&#8217;s proxy solicitor, D.F. King, by calling (800) 331-7024 or emailing </font><u><font style="font-weight: bold;">AMRN@dfking.com</font></u></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Amarin is in dire need of change. Sarissa believes the current regime is wasting a uniquely valuable opportunity. Vascepa is a highly attractive asset that can not only meaningfully improve
      patients&#8217; lives by reducing cardiovascular events but also save significant money for health systems worldwide. The board, led by Chairman Wold-Olsen, has failed shareholders and takes no accountability for its failures. Sarissa urges shareholders to
      act now to support change so that the current leadership does not continue its misguided stewardship of shareholder capital.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">#FreeAmarin</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Visit our website at <u>www.freeamarin.com</u><font style="color: rgb(5, 99, 193);">&#160;</font>for helpful information about Sarissa and the need for change at Amarin.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Vote &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the Sarissa Nominees and &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the removal of Chairman Per Wold-Olsen.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">The General Meeting of Amarin shareholders is scheduled for February 28, 2023, BUT TO MAKE SURE YOUR VOTE COUNTS, <font style="font-weight: bold;"><u>SUBMIT YOUR VOTE ON OR BEFORE TUESDAY,
          FEBRUARY 21, 2023</u></font>.</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Shareholders should have received the <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font><font style="color: rgb(0, 32, 96);">&#160;</font>proxy card. If you have not received your <font style="font-weight: bold; color: rgb(0, 32, 96);">BLUE</font><font style="color: rgb(0, 32, 96);">&#160;</font>proxy card or have any questions on how to vote, please contact:</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">D.F. King &amp; Co., Inc.</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">48 Wall Street</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">New York, New York 10005</div>
    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Shareholders call toll-free:</font><font style="font-size: 10pt;"> (800) 331-7024</font></div>
    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Banks and Brokers call:</font><font style="font-size: 10pt;"> (212) 269-5550</font></div>
    <div style="text-align: center; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">By Email:</font><font style="font-size: 10pt;">&#160;<u><font style="font-family: 'Times New Roman',Times,serif;">AMRN@dfking.com</font></u></font></div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">* 2021 stock performance calculated from end of day December 31, 2020 &#8211; December 31, 2021. Source: Bloomberg</div>
    <div style="font-family: 'Times New Roman',Times,serif;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#8224;</sup> 2022 stock performance calculated from end of day December 31, 2021 &#8211; December 30, 2022. Source: Bloomberg</div>
    <div style="font-family: 'Times New Roman',Times,serif;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#8225;</sup> Calculated based on corporate filings</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif; font-weight: bold;">Additional Information</div>
    <div>&#160;</div>
    <div style="font-family: 'Times New Roman',Times,serif;">Sarissa Capital Management LP (&#8220;Sarissa Capital&#8221;), together with other participants, filed a definitive proxy statement and an accompanying blue proxy card with the SEC on January 31, 2023, in
      connection with the solicitation of shareholders of Amarin Corporation plc (the &#8220;Company&#8221;) at the general meeting of the Company for the election of Sarissa Capital&#8217;s slate of highly-qualified nominees (the &#8220;General Meeting&#8221;). Shareholders are
      advised to read the definitive proxy statement and other relevant documents related to the General Meeting as they contain important information.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">The definitive proxy statement and other relevant documents are available at no charge on the SEC&#8217;s website at <u>www.sec.gov</u> and at <u>www.freeamarin.com</u>. The definitive proxy
      statement and other relevant documents are also available at no charge by directing a request to Sarissa Capital&#8217;s proxy solicitor, D.F. King &amp; Co., Inc., 48 Wall Street, New York, New York 10005 (Shareholders can call toll-free: (800) 331-7024).</div>
    <div>&#160;</div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3e384c456ee44dc9a1275535b566cd9d" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 72pt; vertical-align: top; font-family: 'Times New Roman',Times,serif;">Contact:</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-family: 'Times New Roman',Times,serif;">Jean Puong<br>
              Sarissa Capital Management LP<br>
              info@sarissacap.com</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    <div><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
